诱导NF-κB激酶通过调节非正规NF-κB介导的结肠上皮细胞再生来减弱结肠直肠癌
Holly A Morrison1, Kristin Eden2, Brie Trusiano1
1Virginia Tech, Virginia Maryland College of Veterinary Medicine, Department of Biomedical Science and Pathobiology, Blacksburg, Virginia.
概括
诱导NF-κB激酶 (NIK) 调节结肠上皮细胞的再生和分化,这对于预防结肠直肠癌的发展至关重要. 它在非正规NF-κB信号传递中的失调有助于炎症和瘤生长.
科学领域:
- 胃肠病学 胃肠病学
- 癌症生物学 癌症生物学
- 免疫学 免疫学 免疫学
背景情况:
- 结肠直肠癌 (CRC) 的发展与失调的结肠上皮细胞 (CEC) 增殖有关.
- 非正规的NF-κB信号,由NF-κB诱导激酶 (NIK) 主导,在CEC再生和分化中发挥作用.
- 了解NIK的作用对于开发新型CRC疗法至关重要.
研究的目的:
- 调查NIK在结直肠癌发病过程中的作用.
- 阐明NIK调节CEC再生和差异化的机制.
- 确定NIK介导的CRC抑制中涉及的特定信号通路.
主要方法:
- 在实验室中使用来自NIK淘汰赛小鼠的结肠密室和器官的研究.
- 转录组分析分析NIK缺乏细胞中的基因表达变化.
- 在体内研究中,使用NIK淘汰赛小鼠诱导结肠炎和炎症驱动的瘤发生模型.
主要成果:
- 在CEC中NIK缺乏导致再生功能受损,分化发生变化,并增加对结肠炎和CRC的易感性.
- 在人类CRC转录组数据中观察到非正规NF-κB信号失调.
- 尼克在抑制CRC中的作用依赖于组织,主要在CEC中起作用,而不是在髓状细胞中.
结论:
- 尼克是胃肠道炎症和再生的关键调节者,影响结肠直肠癌的发展.
- 通过NIK介导的失调的非正规NF-κB信号传输,以组织特异的方式与CRC相关.
- 准NIK可能通过调节炎症和再生来为结直肠癌提供治疗策略.
相关概念视频
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.1K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Co-activators and Co-repressors
7.3K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.3K
MAPK Signaling Cascades
5.4K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.4K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K


